KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Sales and Divestitures: 2010-2019

Historic Gains from Sales and Divestitures for Exact Sciences (EXAS) over the last 7 years, with Sep 2019 value amounting to $3.8 million.

  • Exact Sciences' Gains from Sales and Divestitures rose 214.88% to $3.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.8 million, marking a year-over-year increase of 214.88%. This contributed to the annual value of $1.3 million for FY2018, which is 12.85% up from last year.
  • According to the latest figures from Q3 2019, Exact Sciences' Gains from Sales and Divestitures is $3.8 million, which was up 8.63% from $3.5 million recorded in Q2 2019.
  • In the past 5 years, Exact Sciences' Gains from Sales and Divestitures ranged from a high of $3.8 million in Q3 2019 and a low of $237,061 during Q1 2015.
  • Over the past 3 years, Exact Sciences' median Gains from Sales and Divestitures value was $1.1 million (recorded in 2017), while the average stood at $1.7 million.
  • Data for Exact Sciences' Gains from Sales and Divestitures shows a peak YoY surged of 286.50% (in 2019) over the last 5 years.
  • Over the past 5 years, Exact Sciences' Gains from Sales and Divestitures (Quarterly) stood at $578,033 in 2015, then soared by 37.74% to $796,168 in 2016, then spiked by 42.21% to $1.1 million in 2017, then grew by 12.85% to $1.3 million in 2018, then soared by 214.88% to $3.8 million in 2019.
  • Its last three reported values are $3.8 million in Q3 2019, $3.5 million for Q2 2019, and $3.4 million during Q1 2019.